Equity
€20,021 ▼ 6.3%
CORPOSYS paid out €1,722 in dividends. That is 471% of the 2025 profit.
CORPOSYS
Lifetime
13 annual accounts with figures on one time axispeak €7,785 (2015)
€1,456▲ 0.9%
peak €3,870 (2013)
€366▼ 2.6%
peak €21,981 (2023)
€20,021▼ 6.3%
€3,424▲ 31.3%
Board1 name since 2013
1 director
Documentsfilings and deeds
08-07-202623 days before the deadline
2025micro format
Dividend €1,722Debts from €2,608 to €3,424
Key points
from the 2025 annual accountsFilings
13 annual accounts since 2013
Five of the last ten came late. The 2018 accounts came latest: 40 days after the end of the period.
Position in the sector
85.4%
Higher solvency than 86% of companies in wholesale trade. Sector median 40.5% · 15,454 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 10,915 companies had the same profile as CORPOSYS has now. Each dot stands for 28 companies, two years later.
95.0%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,915 companies, not a prediction for CORPOSYS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0515962301
Appointment: (director)
General meeting of 14-12-2023 · Gazette deed
First establishment
Rue du Tillet 51, Verviers
Incorporation
published on 06-03-2013 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CORPOSYS Verviers | €23,446 | €1,456 | 85.4% | - |
| Medica BNL Jabbeke | €15,087 | -€7,647 | 25.3% | - |
| MED INSPIRE Brussels | €18,200 | -€35,979 | 59.7% | - |
| Trend Management et Marketing Waterloo | €44,372 | -€6,884 | 24.9% | - |
| Pharmaceutical industries Advice Rixensart | €27,340 | -€72 | 97.8% | - |
| WORLD OF MEDICAL TECHNOLOGY Sint-Gillis (bij-Brussel) | €41,190 | -€835 | 72.6% | - |
| SANMEDEX Uccle | €50,961 | -€571 | -75.5% | - |
These companies have the same main activity as CORPOSYS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €15,100 and €51,000, founded between 2006 and 2016.
Official details
Source: KBO- Status
- Active since 25-02-2013Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Establishment unit
- 2.217.178.2904800 Verviers, since 13-03-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 30-12-2025
Annual accounts 2025
- ≈ €17,000estimated
- €23,446▼ 2.3%
- Filing
- Filed on 08-07-2026, 23 days before the end of the filing period
Insights on CORPOSYS
CORPOSYS files the micro format. That format states no turnover. The gross margin fell from €7,275 in 2013 to €1,456 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CORPOSYS
- What is the company number of CORPOSYS?
- The company number of CORPOSYS is 0515.962.301. The VAT number is the same number with BE in front: BE 0515.962.301.
- Where is CORPOSYS based?
- The registered office is at Rue du Tillet 51, 4800 Verviers.Company details
- What does CORPOSYS do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of CORPOSYS?
- CORPOSYS is a private limited company (BV).
- When was CORPOSYS founded?
- CORPOSYS was founded on 25-02-2013.
- Is CORPOSYS still active?
- Yes, CORPOSYS is an active enterprise in the KBO register.
- What is the turnover of CORPOSYS?
- The turnover in financial year 2025 is ≈ €17,000. This figure is estimated from the gross margin of €1,456 and 53 comparable companies (NACE 464). It probably lies between €8,600 and €48,000. It is a rough estimate.Financials
- Is CORPOSYS profitable?
- In financial year 2025, CORPOSYS made a profit of €366.
- Where can I find the annual accounts of CORPOSYS?
- CORPOSYS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CORPOSYS due?
- CORPOSYS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.